Agents Need to Become Welcome
نویسندگان
چکیده
To succeed, agents need to become part of legacy and future systems that are not agent oriented. That means agents must be able to run (and migrate) on servers that are not based on multi-agent platforms. Also, agents will have to be able to communicate using languages and protocols that are not dedicated to them, such as HTML. Last, agents need to be able to adapt (themselves) to modifications of their environment. Such features are provided by a family of agents developed at CRIM, which we call Guest.
منابع مشابه
Welcome to virosphere
Viruses may seem alien, but they are the most abundant and, arguably, the most important organisms on Earth. They are found just about everywhere, from oceans and forests to the people around you and, of course, in and on you as well. This world of strange, quasi-living things has been dubbed the virosphere, and it is a mysterious one – we know less about viruses than any other life form. But t...
متن کاملEditor\'s welcome
Food and Nutrition Security (FNS) has an evolving nature and during the last decades its theoretical, conceptual, structural, practical and programmatic notions evolved significantly and approaches toward food and nutrition have changed drastically. Now, more than ever before, the issue is considered as a fundamental component of sustainable development globally. For a better grasp of the compl...
متن کاملبررسی عوامل موثر بر ماندگاری سوخت دی متیل هیدرازین نامتقارن
One of the difficulties of the liquid fuels is theirs shelf life because these fuels like other chemical materials become off spec after a period of time due to the tendency to the destructive reactions. This variation in fuel spec affects the chemical and physical properties of fuel and therefore the combustion performance. This subject is significant because of need to long time storage of fu...
متن کاملPonatinib: Accelerated Disapproval.
Drug development for life-threatening diseases is still a process in evolution. In oncology, as drugs have become more targeted, the regulatory path to drug approval has shortened, with increasing reliance on the Accelerated Approval pathway to provide early access to active agents. However, this approach is not without risks, as illustrated by the recent experience with ponatinib, a promising ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2002